NCT00240747View on ClinicalTrials.gov

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

PHASE3TerminatedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Study Completion Date

January 31, 2005

Conditions
Gram-Positive Bacterial Infections
Interventions
DRUG

Synercid

Trial Locations (6)

27705

Duke University Medical Center, Durham

44195

The Cleveland Clinic, Cleveland

45267

Children's Hospital, Cincinnati

74136

Children's Hospital at Saint Francis, Tulsa

92868

Children's Hospital of Orange County, Orange

94609

Children's Hospital, Oakland

Sponsors

Lead Sponsor

Pfizer

Collaborators (1)

Aventis Pharmaceuticals
All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Pfizer

INDUSTRY